Taiwan chipmaker TSMC (2330.TW) said on Sunday it was in the middle of the contract signing process to buy COVID-19 vaccines from Germany's BioNTech SE (22UAy.DE), part of a drawn out and highly politicised process for Taiwan to access the shot.
Taiwan's government has tried for months to buy the vaccine directly from BioNTech and has blamed China, which claims the self-ruled island as its own territory, for nixing a deal the two sides were due to sign earlier this year. China denies the accusations.
, as well as Taiwan Semiconductor Manufacturing Co to negotiate on its behalf for the vaccines, which would be donated to Taiwan's government for distribution. Speaking to reporters on Sunday, Premier Su Tseng-chang would only say that talks for the vaccine were ongoing.A source briefed on the matter told Reuters that contract talks were "not yet 100% complete", while another source said while they were close to finalising the deal, uncertainties remained.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer to seek OK for a booster dose of its COVID-19 vaccinePfizer says it is planning to seek authorization from the Food and Drug Administration for a third dose of its COVID-19 vaccine as a booster shot.
Read more »
U.S. administers nearly 333.6 mln doses of COVID-19 vaccines- CDCThe United States had administered 333,565,404 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 386,985,420 doses, the U.S. Centers for Disease Control and Prevention (CDC) said on its website.
Read more »
Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer saysPfizer and BioNTech say booster shot delivered about six months after the second shot likely to provide best protection from COVID-19, according to initial data.
Read more »
Moderna Begins Human Study Of MRNA-Based Flu Shot After Covid SuccessModerna is aiming to employ the technology used to make its Covid-19 shot to produce a more effective flu vaccine.
Read more »
Moderna Begins Human Study Of MRNA-Based Flu Shot After Covid SuccessModerna is aiming to employ the technology used to make its Covid-19 shot to produce a more effective flu vaccine.
Read more »
Rob Schneider Suggests Using Guns Against Potential of 3rd VaccineSchneider doubles down on his hesitancy to get the COVID-19 vaccine, or any others that may follow.
Read more »